SCHEMBL3601588

SCHEMBL3601588

CCc1c(C(C)C)nn(C)c1Oc1cc(O[C@@H](C)C(=O)O)c(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 3/20 0.42
TSHR P16473 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 1/20 0.36
PPARG P37231 6/20 0.34
RAB9A P51151 1/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
MAPT P10636 1/20 0.33
PTGDR2 Q9Y5Y4 3/20 0.33
PTGDR Q13258 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3610909 0.92 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3610789 0.88 KDM4E (0.43) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3605184 0.88 KDM4E (0.43) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3609640 0.85 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3599896 0.85 KDM4E (0.40) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3609672 0.84 ALDH1A1 (0.37) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3611068 0.84 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3596021 0.82 KDM4E (0.40) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3608007 0.82 KDM4E (0.39) ALDH1A1KDM4EHSD17B10TSHRHTR2A
SCHEMBL3609981 0.82 KDM4E (0.39) ALDH1A1KDM4EHSD17B10TSHRHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885KDM4E 2049/4885HSD17B10 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.